AbCellera Biologics Inc (NASDAQ: ABCL) is -26.96% lower on its value in year-to-date trading and has touched a low of $1.89 and a high of $4.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.02 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $2.14, the stock is 4.85% and -4.30% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.02 million and changing 5.94% at the moment leaves the stock -19.36% off its SMA200. ABCL registered -47.55% loss for a year compared to 6-month loss of -24.38%. The firm has a 50-day simple moving average (SMA 50) of $2.241 and a 200-day simple moving average (SMA200) of $2.656375.
The stock witnessed a -14.06% gain in the last 1 month and extending the period to 3 months gives it a -9.32%, and is 8.63% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.06% over the week and 3.55% over the month.
AbCellera Biologics Inc (ABCL) has around 596 employees, a market worth around $638.76M and $23.12M in sales. Profit margin for the company is -726.23%. Distance from 52-week low is 13.19% and -49.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.45%).
The EPS is expected to shrink by -13.51% this year.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
179.0 institutions hold shares in AbCellera Biologics Inc (ABCL), with institutional investors hold 58.04% of the company’s shares. The shares outstanding are 298.36M, and float is at 223.95M with Short Float at 10.05%. Institutions hold 44.71% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
